Trial intelligence / Profile preview

Traditional Chinese Medicine vs Oseltamivir for Influenza

ChiCTR2100045928Phase 4Recruiting

Sponsor
Nanfang Hospital, Southern Medical University
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of oseltamivir and bazhengsan in influenza (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoints: Cough, Sore throat and 2 more. Started May 2019; status: recruiting.

02

Drugs

oseltamivirbazhengsan
03

Conditions

influenza

Beyond the preview

Go deeper on ChiCTR2100045928.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100045928.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call